 |
|
Intrafamilial variability and clinical heterogeneity in a family with PLA2G6-associated neurodegeneration
Jong Kyu Park, Jinyoung Youn, Jin Whan Cho
Precis Future Med. 2019;3(3):135-138. Published online 2019 Sep 24 DOI: https://doi.org/10.23838/pfm.2019.00086
|
|
Citations to this article as recorded by
 Dissecting the Phenotype and Genotype of PLA2G6‐Related Parkinsonism
Francesca Magrinelli, Sahil Mehta, Giulia Di Lazzaro, Anna Latorre, Mark J. Edwards, Bettina Balint, Purba Basu, Christopher Kobylecki, Sergiu Groppa, Anaita Hegde, Eoin Mulroy, Carlos Estevez‐Fraga, Anshita Arora, Hrishikesh Kumar, Susanne A. Schneider,
Movement Disorders.2022; 37(1): 148. CrossRef Clinical Characterization and Founder Effect Analysis in Chinese Patients with Phospholipase A2-Associated Neurodegeneration
Hao-Ling Cheng, Yi-Jun Chen, Yan-Yan Xue, Zhi-Ying Wu, Hong-Fu Li, Ning Wang
Brain Sciences.2022; 12(5): 517. CrossRef New Insights of Phospholipase A2 Associated Neurodegeneration Phenotype Based on the Long-Term Follow-Up of a Large Hungarian Family
Renata Toth-Bencsik, Peter Balicza, Edina Timea Varga, Andras Lengyel, Gabor Rudas, Aniko Gal, Maria Judit Molnar
Frontiers in Genetics.2021;[Epub] CrossRef
|